|Videos|May 19, 2020

New Normals of Outpatient Care in a Post-COVID Society

Monica V. Mahoney, PharmD, BCPS AQ-ID, BCIDP chats with assistant editor Grant M. Gallagher on the evolving nature of outpatient infectious disease care in light of the COVID-19 pandemic.

Segment Description: Dr. Monica V. Mahoney (PharmD, BCPS AQ-ID, BCIDP) chats with assistant editor Grant M. Gallagher on the evolving nature of outpatient infectious disease care in light of the COVID-19 pandemic. Dr. Mahoney is a Clinical Pharmacy Specialist at Beth Israel Deaconess Medical Center.

More with Dr. Mahoney: Monica V. Mahoney shares an anti-microbial stewardship #StewardTip:

"Antimicrobial stewardship doesn't just end with the workday! It extends well beyond into every day practice. We can have a profound impact by educating our family and friends to avoid unnecessary antibiotics in everyday, casual conversation. Especially now, we can educate that antibiotics have no role in viral infections. Just the other day, I talked my brother out of filling a levofloxacin prescription for the tail end of the flu, because he still 'wasn't better.' A few more days of rest and he was on his way to recovery, sans antibiotic."


Related to this article

How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.